Free Newsletter
Gene therapy could offer AIDS cure
New hope for an AIDS cure: An AIDS patient being treated for leukemia received a bone marrow transplant that may have cured him of the deadly disease.
When American AIDS patient living in Berlin needed the a bone marrow transplant after failing first-line leukemia treatment. Hematologist Dr. Gero Hütter pursued the standard second-line treatment--a bone marrow transplant--but used marrow from a donor who had a natural genetic mutation that made him immune to HIV. The patient is still recovering from leukemia but since getting the transplant, "doctors have not been able to detect the virus in his blood for more than 600 days, despite his having ceased all conventional AIDS medication. Normally when a patient stops taking AIDS drugs, the virus stampedes through the body within weeks, or days," report the Wall Street Journal.
About 1 percent of Europeans harbor a genetic mutation which prevents the molecule CCR5 from appearing on the surface of a cell. Most HIV strains require CCR5 to be present in order to infect the cell, so people who don't carry it are virtually immune to the disease. This case offers new hope that researchers could use gene therapy to re-engineer patients' own genetics to over come a disease that has defeated scientists for decades.
- see the Wall Street Journal article
Related Articles:
Gene therapy helps improve sight of the blind
Gene therapy advance a better way to target genes
Gene therapy makes a big comeback
Trial death spurs questions about gene therapy
Comments
I wanted to do this years ago. But Dr. Connors at NIH said that I would ruin my immune system and its ability to fight HIV. Since HIV will always be in the patients cells. Even after chemo.
Philip@maynezfoundation.org
Amazing! I asked my high-school science teacher this months ago before I stumbled upon this! I'm so happy, I want to cry! These people NEED to be cured!
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities

SHARE
WITH: